Navigation Links
Cancer Treatment Guidelines for Diverse Asian Economies Use Model Developed at Fred Hutchinson Cancer Research Center
Date:10/30/2009

SEATTLE, Oct. 30 /PRNewswire/ -- When the prestigious British medical journal The Lancet Oncology this week published six cancer treatment guideline papers aimed at the resource-diverse nations of Asia, it used as its model the economic template developed by the Breast Health Global Initiative (BHGI) based at Fred Hutchinson Cancer Research Center. It was an important affirmation that the BHGI's unique resource-stratification approach to cancer treatment guidelines for low- and moderate-income countries is a viable model.

"Asia represents a tremendous clinical challenge: Cancer incidence is increasing rapidly; lifestyles are becoming more westernized causing changes in disease etiology; and resources for infrastructure and disease management vary widely from country to country," The Lancet Oncology editors said in their introduction to the papers. "For any clinical guidance to be universally applicable these differences need to be taken into account. The Breast Health Global Initiative provides an excellent economic template on how to achieve this goal."

Founded in 2002, the BHGI strives to develop evidence-based, economically feasible and culturally appropriate guidelines for underdeveloped nations to improve breast-health outcomes. BHGI is co-sponsored by the Hutchinson Center and the Susan G. Komen for the Cure. Benjamin O. Anderson, M.D., is founder, chair and director. He is a member of the Division of Public Health Sciences at Fred Hutchinson Cancer Research Center, director of the Breast Health Clinic at the Seattle Cancer Care Alliance and professor of surgery and global health medicine at the University of Washington.

"The BHGI guidelines are intended to assist ministers of health, policymakers, administrators and institutions in prioritizing resource allocation as breast cancer treatment programs are implemented and developed in their resource-constrained countries," Anderson said. "The guidelines are defined by levels of resources and offer evidence-based pathways for coordinated, step-by-step quality improvements. This systematic approach applies a tiered system of resource allotment: basic, limited, enhanced and maximal, and is based on the contribution of each resource toward improving clinical outcomes."

The papers published by The Lancet Oncology in its November 2009 issue cover management of a variety of malignancies: HER-2 positive breast cancer, neck cancer, T-cell and natural-killer-cell neoplasms, advanced non-small-cell lung cancer, liver cancer and endometrial cancer. The guidelines represent consensus statements from the 2009 Asian Oncology Summit held last April in Singapore. The journal co-hosted the event.

"I was tremendously impressed and pleased with how this worked and how the different key opinion leaders were brought together in the Asian Oncology Summit," Anderson said. "It was a great learning experience for me in addition to the fact that it was a demonstration that this stratified guideline approach is in fact useful and functional."

The first broad dissemination of the BHGI guidelines came in October 2008 when journal Cancer published a special supplement, "Guidelines for International Breast Health and Cancer Control," which detailed guidelines for low- and middle-income countries to implement programs to detect and treat breast cancer, the most common disease among women worldwide.

More information about The Lancet Oncology cancer papers can be found on its Web site here: http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(09)70324-9/fulltext

More information about the BHGI can be found on its Web site: www.bhgi.info

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit fhcrc.org.

    CONTACT
    Dean Forbes
    206-667-2896
    dforbes@fhcrc.org

SOURCE Fred Hutchinson Cancer Research Center


'/>"/>
SOURCE Fred Hutchinson Cancer Research Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... environments  Oticon , industry leaders in ... the launch of Oticon Opn ™, the world,s ... world of possibilities for IoT devices.      ... Opn, Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
Breaking Medicine News(10 mins):